Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson’s disease

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Ferroptosis and cell death mechanisms in Parkinson’s disease.

References

  1. 1.

    Angelova PR, Choi ML, Berezhnov AV, Horrocks MH, Hughes CD, De S, et al. Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ. 2020;27:2781–96.

    CAS  Article  Google Scholar 

  2. 2.

    Cao J, Chen X, Jiang L, Lu B, Yuan M, Zhu D, et al. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun. 2020;11:1251.

    CAS  Article  Google Scholar 

  3. 3.

    Vallerga CL, Zhang F, Fowdar J, McRae AF, Qi T, Nabais MF, et al. Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nat Commun. 2020;11:1238.

    CAS  Article  Google Scholar 

  4. 4.

    Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510:278–83.

    CAS  Article  Google Scholar 

  5. 5.

    Angelopoulou E, Piperi C, Papavassiliou AG. High-mobility group box 1 in Parkinson’s disease: from pathogenesis to therapeutic approaches. J Neurochem. 2018;146:211–8.

    CAS  Article  Google Scholar 

  6. 6.

    Zhang P, Chen L, Zhao Q, Du X, Bi M, Li Y, et al. Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson’s disease. Free Radic Bio Med. 2020;152:227–34.

    CAS  Article  Google Scholar 

  7. 7.

    Nishizawa H, Matsumoto M, Shindo T, Saigusa D, Kato H, Suzuki K, et al. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J Biol Chem. 2020;295:69–82.

    CAS  Article  Google Scholar 

  8. 8.

    Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, et al. GTP cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41–53.

    CAS  Article  Google Scholar 

  9. 9.

    Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278–90.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (No. 81402951 to JC), Leading Talent of “Ten Thousand Plan”-National High-Level Talents Special Support Plan, and the Talent Project of Zhejiang Association for Science and Technology (No. 2018YCGC002 to JC).

Author information

Affiliations

Authors

Contributions

HYZ and JC wrote the manuscript; QJH, BY, and JC directed the paper.

Corresponding author

Correspondence to Ji Cao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, Hy., He, Qj., Yang, B. et al. Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson’s disease. Acta Pharmacol Sin 42, 1379–1381 (2021). https://doi.org/10.1038/s41401-020-00555-7

Download citation

Search

Quick links